Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.05.2012 | Case report

Antibacterials/immunomodulators

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H.Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. Journal of Clinical Microbiology 50: 1109-1112, No. 3, Mar 2012. Available from: URL: http://dx.doi.org/10.1128/jcm.06161-11 - Austria Vossen MG, Gattringer KB, Khalifeh N, Koreny M, Spertini V, Mallouhi A, Willeit M, Volc-Platzer B, Asboth F, Graninger W, Thalhammer F, Lagler H.Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. Journal of Clinical Microbiology 50: 1109-1112, No. 3, Mar 2012. Available from: URL: http://​dx.​doi.​org/​10.​1128/​jcm.​06161-11 - Austria
Metadaten
Titel
Antibacterials/immunomodulators
Various toxicities: case report
Publikationsdatum
01.05.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214020-00033

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Erlotinib